Publication: H3K4 acetylation, H3K9 acetylation and H3K27 methylation in breast tumor molecular subtypes
| dc.contributor.author | KARSLI, SEHER | |
| dc.contributor.authors | Judes, Gaelle; Dagdemir, Aslihan; Karsli-Ceppioglu, Seher; Lebert, Andre; Echegut, Maureen; Ngollo, Marjolaine; Bignon, Yves-Jean; Penault-Llorca, Frederique; Bernard-Gallon, Dominique | |
| dc.date.accessioned | 2022-03-12T20:30:03Z | |
| dc.date.accessioned | 2026-01-11T14:34:38Z | |
| dc.date.available | 2022-03-12T20:30:03Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | Aim: Here, we investigated how the St Gallen breast molecular subtypes displayed distinct histone H3 profiles. Patients & methods: 192 breast tumors divided into five St Gallen molecular subtypes (luminal A, luminal B HER2-, luminal B HER2+, HER2+ and basal-like) were evaluated for their histone H3 modifications on gene promoters. Results: ANOVA analysis allowed to identify specific H3 signatures according to three groups of genes: hormonal receptor genes (ERS1, ERS2, PGR), genes modifying histones (EZH2, P300, SRC3) and tumor suppressor gene (BRCA1). A similar profile inside high-risk cancers (luminal B [HER2+], HER2+ and basal-like) compared with low-risk cancers including luminal A and luminal B (HER2-) were demonstrated. Conclusion: The H3 modifications might contribute to clarify the differences between breast cancer subtypes. | |
| dc.identifier.doi | 10.2217/epi-2016-0015 | |
| dc.identifier.eissn | 1750-192X | |
| dc.identifier.issn | 1750-1911 | |
| dc.identifier.pubmed | 27424567 | |
| dc.identifier.uri | https://hdl.handle.net/11424/234144 | |
| dc.identifier.wos | WOS:000381034100005 | |
| dc.language.iso | eng | |
| dc.publisher | FUTURE MEDICINE LTD | |
| dc.relation.ispartof | EPIGENOMICS | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | breast cancer | |
| dc.subject | H3 modifications | |
| dc.subject | St Gallen molecular subtypes | |
| dc.subject | INTERNATIONAL EXPERT CONSENSUS | |
| dc.subject | HISTONE MODIFICATIONS | |
| dc.subject | DNA HYPERMETHYLATION | |
| dc.subject | DEVELOPMENTAL GENES | |
| dc.subject | CANCER HIGHLIGHTS | |
| dc.subject | BRCA1 EXPRESSION | |
| dc.subject | PRIMARY THERAPY | |
| dc.subject | ESTROGEN | |
| dc.subject | ASSOCIATION | |
| dc.subject | HER-2/NEU | |
| dc.title | H3K4 acetylation, H3K9 acetylation and H3K27 methylation in breast tumor molecular subtypes | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 924 | |
| oaire.citation.issue | 7 | |
| oaire.citation.startPage | 909 | |
| oaire.citation.title | EPIGENOMICS | |
| oaire.citation.volume | 8 |
